Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.51 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.48 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19520657 | 1.00 | F2 (0.54) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL9314374 | 1.00 | F2 (0.54) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL1239590 | 1.00 | F2 (0.54) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL342640 | 1.00 | F2 (0.54) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL20502714 | 1.00 | F2 (0.54) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL6497247 | 0.96 | F2 (0.57) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL2119635 | 0.96 | F2 (0.57) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL2778546 | 0.96 | F2 (0.57) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL6850160 | 0.96 | F2 (0.57) | F2OPRM1OPRD1OPRK1NPFFR1 | |
| SCHEMBL2778544 | 0.96 | F2 (0.57) | F2OPRM1OPRD1OPRK1NPFFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1853104-B | Protocol and apparatus for determining heparin-induced thrombocytopenia | HAEMOSCOPE CORP | 2013-04-10 | — | — | CN | claimed |
| CN-114295821-A | Indoor quality assessment sample of thrombus elastogram experimental reagent and preparation method and application thereof | 深圳麦科田生物医疗技术股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-110514851-A | The detection method and detection kit of blood platelet inhibiting rate | MEDCAPTAIN MEDICAL TECH CO LTD | 2019-11-29 | — | — | CN | disclosed |
| CN-1853104-B | Protocol and apparatus for determining heparin-induced thrombocytopenia | HAEMOSCOPE CORP | 2013-04-10 | — | — | CN | disclosed |
| US-7811792-B2 | using a hemostasis analyzer is to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters | CORA HEALTHCARE, INC. (US) | 2010-10-12 | — | — | US | disclosed |
| EP-1649292-B1 | PROTOCOL FOR DETERMINING HEPARIN-INDUCED THROMBOCYTOPENIA | CORA HEALTHCARE INC (US) | 2010-04-21 | — | — | EP | disclosed |
| US-20090208988-A1 | Protocol and Apparatus for Determining Heparin-induced Thrombocytopenia | CORA HEALTCARE, INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-7524670-B2 | Protocol and apparatus for determining heparin-induced thrombocytopenia | HAEMOSCOPE CORPORATION (US) | 2009-04-28 | — | — | US | disclosed |
| CN-1853104-A | Protocol and apparatus for determining heparin-induced thrombocytopenia | HAEMOSCOPE CORP (US) | 2006-10-25 | — | — | CN | disclosed |
| EP-1649292-A1 | PROTOCOL AND APPARATUS FOR DETERMINING HEPARIN-INDUCED THROMBOCYTOPENIA | Haemoscope Corporation (US) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005017534-A1 | PROTOCOL AND APPARATUS FOR DETERMINING HEPARIN-INDUCED THROMBOCYTOPENIA | HAEMOSCOPE CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20050032142-A1 | Protocol and apparatus for determining heparin-induced thrombocytopenia | HAEMONETICS CORPORATION | 2005-02-10 | — | — | US | disclosed |